A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Compass Therapeutics
Compass Therapeutics
Wake Forest University Health Sciences
Memorial Sloan Kettering Cancer Center
St. Jude Children's Research Hospital
Mayo Clinic
IRCCS Azienda Ospedaliero-Universitaria di Bologna
University Medical Center Groningen